"IL-1β Blockade to Prevent Immunothrombosis in Recipients of a Pancreatic Organ"
"IL-1β Blockade to Prevent Immunothrombosis in Recipients of a Pancreatic Organ"
Not yet recruiting · NCT07503834 · Registry updated 2026-03-31Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| "IL-1β Blockade to Prevent Immunothrombosis in Recipients of a Pancreatic Organ" | Embolism and Thrombosis, Hemic and Lymphatic Diseases, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thromboinflammation, blood coagulation disease, cardiovascular disorder, hematologic disorder, thrombotic disease, vascular disorder | Not yet recruiting | Phase 1 / Phase 2 | 2026-03-31 | NCT07503834 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Nantes University Hospital | 223 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| CHU Nantes | Nantes | France | 86 |